Drug profile · INN
5-aminolevulinic acid hydrochloride
AMELUZ
5-aminolevulinic acid hydrochloride (AMELUZ) is a dna inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XD04
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — 5-aminolevulinic acid hydrochloride
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
5-aminolevulinic acid hydrochloride (AMELUZ) is a dna inhibitor.
Key facts
INN 5-aminolevulinic acid hydrochloride
Brand AMELUZ
Mechanism DNA inhibitor
Target DNA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XD04
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is 5-aminolevulinic acid hydrochloride?
5-aminolevulinic acid hydrochloride (AMELUZ) is a dna inhibitor.
What is the brand name for 5-aminolevulinic acid hydrochloride?
AMELUZ is a marketed brand name for 5-aminolevulinic acid hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.